Dr Penny Kechagioglou
MBBS, MRCP, FRCReq, MPH, MBA
Consultant Clinical Oncologist and Group Clinical Director for Surgery and Emergency Medicine, at the University Hospitals Coventry and Warwickshire.
Dr Kechagioglou has served as Chief Medical Officer at Genesis Care UK, the global Integrated Oncology provider and has experience in treating all adult cancers with radiotherapy, chemotherapy, targeted agents, clinical trials and holistic approaches.
After graduating from Cardiff University with Honours in 2003, Dr Kechagioglou completed her Internal Medicine residency in UK and was awarded the CCST in Clinical Oncology in 2010. She also trained in Public Health and Healthcare Management in London, which led to her studying and completing an MBA in 2017. Her research interest is in Leadership and Innovation and she is currently completing a Doctorate degree in Business Administration at Warwick Business School.
Dr Kechagioglou is an experienced Clinical Oncologist and Medical Leader, clinically specialised in the treatment of Breast cancer and with passion for Integrative Oncology. Her commitment into implementing an Integrated Care approach for improving patient outcomes and experience, has led to her joining the British Society of Integrative Oncology and the Functional Medicine Coaching Academy (Institute of Functional Medicine). She is currently studying to become a Functional Medicine Coach whilst continuing with her clinical and leadership roles in the NHS.
Dr Penny Kechagioglou is speaking at 10:15 and 16:30.
View the programme for more information >
British Society for Integrative Oncology
BSIO is the leading professional organisation for integrative oncology in the UK. Their goal is to promote the integration of conventional, nutritional, lifestyle and complementary medicine to improve the lives of people affected by cancer.
The information and content provided on this website and in the programmes of Integrative Oncology UK is intended for information and educational purposes only. Progressive Communications Ltd and the BSIO do not consider that any of the information provided, will treat or cure cancer.